MENU
VRDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viridian Therapeutics (VRDN) Ownership - Who owns Viridian Therapeutics?

Industry: @Biotechnology

Profile

Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.51B
P/E Ratio
N/A
Total Cash
753.24M
Projected Growth
N/A
Total Debt
21.11M
Revenue
302K
Risk (Beta)
1.09
Dividend Yield
N/A
Total Cash/Share
9.51
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price

Fundamentals

VRDN
Capitalization
1.51B
P/E Ratio
N/A
Risk (Beta)
1.09
Dividend Yield
N/A
Total Cash
753M
Total Cash/Share
9.51
Total Debt
21.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
302K
ROE
N/A
Book Value
519M
P/B Ratio
2.91
Cash Flow
N/A
Earnings
-4.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
792K
Current Ratio
18.55
Current Revenue Per Employee
914.89
Dividends Per Share - Security
N/A
EBITDA
-253.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
8.47
Revenue To Assets
-46.71
Shares Held By Institutions
2.14B
Shares Outstanding - Current
79.2M
Total Liabilities
64.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-12.626
View a ticker or compare two or three
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com